394 related articles for article (PubMed ID: 16504004)
1. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
2. The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell lines.
Alao JP; Gamble SC; Stavropoulou AV; Pomeranz KM; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():7. PubMed ID: 16503970
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
[TBL] [Abstract][Full Text] [Related]
4. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC
Mol Cancer; 2006 Oct; 5():40. PubMed ID: 17018141
[TBL] [Abstract][Full Text] [Related]
5. The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts.
Eo HJ; Park GH; Jeong JB
Phytomedicine; 2016 Feb; 23(2):105-13. PubMed ID: 26926171
[TBL] [Abstract][Full Text] [Related]
6. Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1.
Zhou Q; Melkoumian ZK; Lucktong A; Moniwa M; Davie JR; Strobl JS
J Biol Chem; 2000 Nov; 275(45):35256-63. PubMed ID: 10938272
[TBL] [Abstract][Full Text] [Related]
7. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI.
Zuo X; Qin Y; Zhang X; Ning Q; Shao S; Luo M; Yuan N; Huang S; Zhao X
Oncol Rep; 2014 May; 31(5):2358-64. PubMed ID: 24676336
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
10. SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability
Yuan Y; Fan Y; Gao Z; Sun X; Zhang H; Wang Z; Cui Y; Song W; Wang Z; Zhang F; Niu R
Cancer Biol Med; 2020 Aug; 17(3):707-725. PubMed ID: 32944401
[No Abstract] [Full Text] [Related]
11. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
Benzeno S; Lu F; Guo M; Barbash O; Zhang F; Herman JG; Klein PS; Rustgi A; Diehl JA
Oncogene; 2006 Oct; 25(47):6291-303. PubMed ID: 16732330
[TBL] [Abstract][Full Text] [Related]
12. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase.
Kim YB; Lee KH; Sugita K; Yoshida M; Horinouchi S
Oncogene; 1999 Apr; 18(15):2461-70. PubMed ID: 10229197
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells.
Qin C; Burghardt R; Smith R; Wormke M; Stewart J; Safe S
Cancer Res; 2003 Mar; 63(5):958-64. PubMed ID: 12615709
[TBL] [Abstract][Full Text] [Related]
14. Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells.
Yu XJ; Han QB; Wen ZS; Ma L; Gao J; Zhou GB
Cancer Lett; 2012 Sep; 322(2):185-94. PubMed ID: 22410463
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells.
Liu L; Zhang H; Shi L; Zhang W; Yuan J; Chen X; Liu J; Zhang Y; Wang Z
Oncol Rep; 2014 Oct; 32(4):1395-400. PubMed ID: 25109327
[TBL] [Abstract][Full Text] [Related]
17. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.
Okabe H; Lee SH; Phuchareon J; Albertson DG; McCormick F; Tetsu O
PLoS One; 2006 Dec; 1(1):e128. PubMed ID: 17205132
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells.
Hamelers IH; van Schaik RF; Sipkema J; Sussenbach JS; Steenbergh PH
J Biol Chem; 2002 Dec; 277(49):47645-52. PubMed ID: 12364325
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export.
Yoshida M; Horinouchi S
Ann N Y Acad Sci; 1999; 886():23-36. PubMed ID: 10667200
[TBL] [Abstract][Full Text] [Related]
20. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
